Disappointing Trial Results For Panacos
Panacos Pharmaceuticals Inc. (PANC) reported disappointing results for its HIV treatment bevirimat sending the stock price tumbling $1.75 to close at $3.94.
posted by FC Market News at 9:28 AM
0 Comments:
Post a Comment
<< Home